A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness, safety and tolerability of flexibly
dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully treated
by oral antipsychotics and with acute symptom of schizophrenia.